Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 2
1966 3
1967 1
1968 3
1969 2
1970 3
1971 1
1973 4
1974 1
1975 4
1976 8
1977 3
1978 7
1979 6
1980 7
1981 9
1982 19
1983 13
1984 14
1985 14
1986 12
1987 15
1988 16
1989 26
1990 22
1991 24
1992 23
1993 26
1994 48
1995 50
1996 34
1997 48
1998 46
1999 67
2000 58
2001 80
2002 65
2003 86
2004 106
2005 163
2006 137
2007 162
2008 198
2009 212
2010 234
2011 243
2012 272
2013 303
2014 320
2015 349
2016 430
2017 454
2018 394
2019 416
2020 581
2021 628
2022 634
2023 613
2024 623
2025 701
2026 100

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,052 results

Results by year

Filters applied: . Clear all
Page 1
Medications for adults with type 2 diabetes: a living systematic review and network meta-analysis.
Nong K, Jeppesen BT, Shi Q, Agoritsas T, Guyatt GH, White H, Gao Y, Agarwal A, Macdonald H, Zou X, Millard T, Schnell O, Marx N, Brosius FC 3rd, McDonald S, Quigley M, Tian X, Fan Q, White B, Mao Y, Pan X, Liu C, Zhai C, Yuan C, Li Q, An J, Gan Y, Wang Y, Jin Y, Sun F, Zhu Z, Rydén L, Standl E, Turner T, Vandvik PO, Li S. Nong K, et al. Among authors: agarwal a. BMJ. 2025 Aug 14;390:e083039. doi: 10.1136/bmj-2024-083039. BMJ. 2025. PMID: 40813122
Cardiovascular, kidney related, and weight loss effects of therapeutics for type 2 diabetes: a living clinical practice guideline.
Agarwal A, Mustafa R, Manja V, Agoritsas T, Macdonald H, Li S, Foroutan F, Rayner D, Rodriguez-Gutierrez R, Åsvold BO, Heen AF, Gabi J, Guo L, Hao Q, Jeppesen BT, Jha V, Nagler E, Odom A, Rodondi N, Shetty S, Vermandere M, Wright R, Guyatt G, Vandvik PO. Agarwal A, et al. BMJ. 2025 Aug 14;390:e082071. doi: 10.1136/bmj-2024-082071. BMJ. 2025. PMID: 40813129 Free PMC article.
A Validated Regulatory Network for Th17 Cell Specification.
Ciofani M, Madar A, Galan C, Sellars M, Mace K, Pauli F, Agarwal A, Huang W, Parkurst CN, Muratet M, Newberry KM, Meadows S, Greenfield A, Yang Y, Jain P, Kirigin FK, Birchmeier C, Wagner EF, Murphy KM, Myers RM, Bonneau R, Littman DR. Ciofani M, et al. Among authors: agarwal a. Cell. 2025 Oct 16;188(21):6096. doi: 10.1016/j.cell.2025.09.015. Epub 2025 Sep 23. Cell. 2025. PMID: 40992377 No abstract available.
Empiric antibiotic therapy for moderate-to-severe community-acquired pneumonia: a systematic review and network meta-analysis.
Ghadimi M, Siemieniuk RAC, Loeb M, Lima JP, Aminaei D, Gomaa H, Wang Y, Hazzan AA, Basmaji J, Yao L, Kim WSH, Grant A, Agarwal A, Motaghi S, Tajika A, Takayama T, Alvarado-Gamarra G, Kirmayr K, Muti Schuenemann GEU, Zandieh S, Das A, Manja V, Momenilandi F, Likhvantsev V, Couban R, Sadeghirad B, Brignardello-Petersen R, Guyatt G. Ghadimi M, et al. Among authors: agarwal a. Clin Microbiol Infect. 2025 Nov;31(11):1807-1815. doi: 10.1016/j.cmi.2025.06.033. Epub 2025 Jun 30. Clin Microbiol Infect. 2025. PMID: 40602496 Free article.
Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 2: Guidelines for Initiating Antitubercular Therapy in Anterior Uveitis, Intermediate Uveitis, Panuveitis, and Retinal Vasculitis.
Agrawal R, Testi I, Bodaghi B, Barisani-Asenbauer T, McCluskey P, Agarwal A, Kempen JH, Gupta A, Smith JR, de Smet MD, Yuen YS, Mahajan S, Kon OM, Nguyen QD, Pavesio C, Gupta V; Collaborative Ocular Tuberculosis Study Consensus Group. Agrawal R, et al. Among authors: agarwal a. Ophthalmology. 2021 Feb;128(2):277-287. doi: 10.1016/j.ophtha.2020.06.052. Epub 2020 Jun 27. Ophthalmology. 2021. PMID: 32603726
Duration of primary/secondary treatment to prevent recurrent venous thromboembolism: a systematic review and meta-analysis.
Li A, Khatib R, Lopes LC, Aloweni F, Lu L, He Q, Wu J, Zhang P, Tang Y, Pavalagantharajah S, Sekercioglu N, Cuello Garcia CA, Koujanian S, Agarwal A, Kennedy SA, Neumann I, Schulman S, Wiercioch W, Rada G, Peseski AM, Ortel TL, Zhang YQ. Li A, et al. Among authors: agarwal a. Blood Adv. 2025 Apr 8;9(7):1742-1761. doi: 10.1182/bloodadvances.2024015371. Blood Adv. 2025. PMID: 40198201 Free PMC article.
A novel alpha-synuclein G14R missense variant is associated with atypical neuropathological features.
Brücke C, Al-Azzani M, Ramalingam N, Ramón M, Sousa RL, Buratti F, Zech M, Sicking K, Amaral L, Gelpi E, Chandran A, Agarwal A, Chaves SR, Fernández CO, Dettmer U, Lautenschläger J, Zweckstetter M, Fernández-Busnadiego R, Zimprich A, Outeiro TF. Brücke C, et al. Among authors: agarwal a. Mol Neurodegener. 2025 Sep 26;20(1):98. doi: 10.1186/s13024-025-00889-y. Mol Neurodegener. 2025. PMID: 41013605 Free PMC article.
8,052 results